{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T05:42:19Z","timestamp":1794462139887,"version":"4.9.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Sarcoglycanopathies are heterogeneous proximo-distal diseases presenting severe muscle alterations. Although there are 6 different sarcoglycan isoforms, sarcoglycanopathies are caused exclusively by mutations in genes coding for one of the four sarcoglycan transmembrane proteins (alpha, beta, gamma and delta) forming the sarcoglycan complex (SGC) in skeletal and cardiac muscle. Little is known about the different roles of the SGC beyond the dystrophin glycoprotein complex (DGC) structural role. Here, we show that SGC proteins are enriched at the post-synaptic membrane of neuromuscular junctions (NMJs). Using a mouse model lacking the beta-sarcoglycan subunit, we describe for the first time that the loss of the SGC in the NMJ area results in alterations of pre- and postsynaptic membrane, as well as a significant reduction of membrane potential. Moreover, using different denervated wild-type mouse models, we demonstrate that nerve presence precedes the sarcoglycan enrichment at NMJ, suggesting a nerve-dependent sarcoglycan expression. Altogether, our findings suggest that pathological decline should no longer be understood only in terms of sarcolemma damage but also in terms of sarcoglycans\u2019 participation in the NMJ. Henceforth, our work paves the way for the identification of new mechanisms involving sarcoglycans and new approaches for the treatment of sarcoglycanopathies.<\/jats:p>","DOI":"10.1038\/s41419-025-07353-1","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T04:16:41Z","timestamp":1737519401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Sarcoglycans are enriched at the neuromuscular junction in a nerve-dependent manner"],"prefix":"10.1038","volume":"16","author":[{"given":"Michela","family":"Gloriani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Cheli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"D\u2019Ercole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Serrat Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biliana","family":"Lozanoska-Ochser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0169-8397","authenticated-orcid":false,"given":"Francesca","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0938-5360","authenticated-orcid":false,"given":"Marina","family":"Bouch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Madaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8565-3374","authenticated-orcid":false,"given":"Carles","family":"S\u00e1nchez Riera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"7353_CR1","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1093\/brain\/awaa228","volume":"143","author":"J Alonso-P\u00e9rez","year":"2020","unstructured":"Alonso-P\u00e9rez J, Gonz\u00e1lez-Quereda L, Bello L, Guglieri M, Straub V, Gallano P, et al. New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy. Brain. 2020;143:2696\u2013708.","journal-title":"Brain"},{"key":"7353_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10048-022-00690-9","volume":"23","author":"M Bardhan","year":"2022","unstructured":"Bardhan M, Anjanappa RM, Polavarapu K, Preethish-Kumar V, Vengalil S, Nashi S, et al. Clinical, genetic profile and disease progression of sarcoglycanopathies in a large cohort from India: high prevalence of SGCB c.544A > C. Neurogenetics. 2022;23:187\u2013202.","journal-title":"Neurogenetics"},{"key":"7353_CR3","doi-asserted-by":"crossref","unstructured":"Marchetti GB, Valenti L, Torrente Y. Clinical determinants of disease progression in patients with beta-sarcoglycan gene mutations. Front Neurol 2021;1:12:657949.","DOI":"10.3389\/fneur.2021.657949"},{"key":"7353_CR4","doi-asserted-by":"crossref","unstructured":"Xie Z, Hou Y, Yu M, Liu Y, Fan Y, Zhang W. et al. Clinical and genetic spectrum of sarcoglycanopathies in a large cohort of Chinese patients. Orphanet J Rare Dis. 2019;14:43.","DOI":"10.1186\/s13023-019-1021-9"},{"key":"7353_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41591-023-02730-9","volume":"30","author":"JR Mendell","year":"2024","unstructured":"Mendell JR, Pozsgai ER, Lewis S, Griffin DA, Lowes LP, Alfano LN, et al. Gene therapy with bidridistrogene xeboparvovec for limb-girdle muscular dystrophy type 2E\/R4: phase 1\/2 trial results. Nat Med. 2024;30:199\u2013206.","journal-title":"Nat Med"},{"key":"7353_CR6","doi-asserted-by":"crossref","unstructured":"Bonnemann CG, Modi R, Noguchi S, Mizuno Y, Yoshida M, Gussoni E. et al. \u03b2\u2013sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet. 1995;11:266\u201373.","DOI":"10.1038\/ng1195-266"},{"key":"7353_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/(SICI)1097-0029(20000201\/15)48:3\/4<167::AID-JEMT5>3.0.CO;2-T","volume":"48","author":"AA Hack","year":"2000","unstructured":"Hack AA, Groh ME, Mcnally EM. Sarcoglycans in muscular dystrophy. Microsc Res Tech. 2000;48:167\u201380.","journal-title":"Microsc Res Tech"},{"key":"7353_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1096\/fj.05-4678fje","volume":"20","author":"R Turk","year":"2006","unstructured":"Turk R, Sterrenburg E, Wees CGC, Meijer EJ, Menezes RX, Groh S, et al. Common pathological mechanisms in mouse models for muscular dystrophies. The FASEB Journal. 2006;20:127\u20139.","journal-title":"The FASEB Journal"},{"key":"7353_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11010-008-9975-2","volume":"323","author":"M Honda","year":"2009","unstructured":"Honda M, Hosoda M, Kanzawa N, Tsuchiya T, Toyo-oka T. Specific knockdown of \u03b4-sarcoglycan gene in C2 C12 in vitro causes post-translational loss of other sarcoglycans without mechanical stress. Mol Cell Biochem. 2009;323:149\u201359. https:\/\/doi.org\/10.1007\/s11010-008-9975-2.","journal-title":"Mol Cell Biochem"},{"key":"7353_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0960-8966(01)00276-0","volume":"12","author":"CG B\u00f6nnemann","year":"2002","unstructured":"B\u00f6nnemann CG, Wong J, Jones KJ, Lidov HGW, Feener CA, Shapiro F, et al. Primary \u03b3-sarcoglycanopathy (LGMD 2C): Broadening of the mutational spectrum guided by the immunohistochemical profile. Neuromuscular Dis. 2002;12:273\u201380. https:\/\/doi.org\/10.1016\/S0960-8966(01)00276-0.","journal-title":"Neuromuscular Dis"},{"key":"7353_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s004010050882","volume":"96","author":"I Higuchi","year":"1998","unstructured":"Higuchi I, Kawai H, Umaki Y, Kawajiri M, Adachi K, Fukunaga H, et al. Different manners of sarcoglycan expression in genetically proven \u03b1-sarcoglycan deficiency and \u03b3-sarcoglycan deficiency. Acta Neuropathol. 1998;96:202\u20136. https:\/\/doi.org\/10.1007\/s004010050882.","journal-title":"Acta Neuropathol"},{"key":"7353_CR12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.ymthe.2017.02.013","volume":"25","author":"ER Pozsgai","year":"2017","unstructured":"Pozsgai ER, Griffin DA, Heller KN, Mendell JR, Rodino-Klapac LR. Systemic AAV-mediated \u03b2-sarcoglycan delivery targeting cardiac and skeletal muscle ameliorates histological and functional deficits in LGMD2E mice. Mol Ther. 2017;25:855\u201369.","journal-title":"Mol Ther"},{"key":"7353_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/gt.2015.80","volume":"23","author":"ER Pozsgai","year":"2016","unstructured":"Pozsgai ER, Griffin DA, Heller KN, Mendell JR, Rodino-Klapac LR. \u03b2-Sarcoglycan gene transfer decreases fibrosis and restores force in LGMD2E mice. Gene Ther. 2016;23:57\u201366.","journal-title":"Gene Ther"},{"key":"7353_CR14","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez Riera C, Lozanoska\u2010ochser B, Testa S, Fornetti E, Bouch\u00e9 M, Madaro L. Muscle diversity, heterogeneity, and gradients: learning from sarcoglycanopathies. Int J Mol Sci. 2021;22(5):2502.","DOI":"10.3390\/ijms22052502"},{"key":"7353_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/jnnp-2017-316736","volume":"89","author":"G Tasca","year":"2018","unstructured":"Tasca G, Monforte M, D\u00edaz-Manera J, Brisca G, Semplicini C, D\u2019Amico A, et al. MRI in sarcoglycanopathies: a large international cohort study. J Neurol Neurosurg Psychiatry. 2018;89:72\u201377. https:\/\/doi.org\/10.1136\/jnnp-2017-316736.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7353_CR16","doi-asserted-by":"publisher","first-page":"19183","DOI":"10.1073\/pnas.0805514105","volume":"105","author":"C Colussi","year":"2008","unstructured":"Colussi C, Mozzetta C, Gurtner A, Illi B, Rosati J, Straino S, et al. HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc Natl Acad Sci USA. 2008;105:19183\u20137. https:\/\/doi.org\/10.1073\/pnas.0805514105.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7353_CR17","doi-asserted-by":"crossref","unstructured":"Hack AA, Cordier L, Shoturma DI, Lam MY, Sweeney HL, Mcnally EM. Muscle degeneration without mechanical injury in sarcoglycan deficiency. Proc Natl Acad Sci USA. 1999;122:2.","DOI":"10.1073\/pnas.96.19.10723"},{"key":"7353_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/brainsci5030275","volume":"5","author":"B Nichols","year":"2015","unstructured":"Nichols B, Takeda S, Yokota T. Nonmechanical roles of dystrophin and associated proteins in exercise, neuromuscular junctions, and brains. Brain Sci. 2015;5:275\u201398.","journal-title":"Brain Sci"},{"key":"7353_CR19","doi-asserted-by":"publisher","first-page":"134833","DOI":"10.1016\/j.neulet.2020.134833","volume":"722","author":"DC Belhasan","year":"2020","unstructured":"Belhasan DC, Akaaboune M. The role of the dystrophin glycoprotein complex on the neuromuscular system. Neurosci Lett. 2020;722:134833. https:\/\/doi.org\/10.1016\/j.neulet.2020.134833.","journal-title":"Neurosci Lett"},{"key":"7353_CR20","doi-asserted-by":"crossref","unstructured":"Grady RM, Zhou H, Cunningham JM, Henry MD, Campbell KP, Sanes JR. Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of the dystrophin-glycoprotein complex. Neuron. 2000;25:279\u201393.","DOI":"10.1016\/S0896-6273(00)80894-6"},{"key":"7353_CR21","doi-asserted-by":"publisher","first-page":"610964","DOI":"10.3389\/fnmol.2020.610964","volume":"13","author":"PM Rodr\u00edguez Cruz","year":"2020","unstructured":"Rodr\u00edguez Cruz PM, Cossins J, Beeson D, Vincent A. The Neuromuscular Junction in Health and Disease: Molecular Mechanisms Governing Synaptic Formation and Homeostasis. Front Mol Neurosci. 2020;13:610964. https:\/\/doi.org\/10.3389\/fnmol.2020.610964.","journal-title":"Front Mol Neurosci"},{"key":"7353_CR22","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3390\/cells8090996","volume":"8","author":"MN Colombo","year":"2019","unstructured":"Colombo MN, Francolini M. Glutamate at the vertebrate neuromuscular junction: from modulation to neurotransmission. Cells. 2019;8:996. https:\/\/doi.org\/10.3390\/cells8090996.","journal-title":"Cells"},{"key":"7353_CR23","doi-asserted-by":"publisher","unstructured":"Lanuza MA, Tom\u00e0s J, Garcia N, Cilleros-Ma\u00f1\u00e9 V, Just-Borr\u00e0s L, Tom\u00e0s M. Axonal competition and synapse elimination during neuromuscular junction development. Curr Opin Physiol. 2018;4:25\u201331. https:\/\/doi.org\/10.1016\/j.cophys.2018.04.001.","DOI":"10.1016\/j.cophys.2018.04.001"},{"key":"7353_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s004410050979","volume":"291","author":"Z Grozdanovic","year":"1997","unstructured":"Grozdanovic Z, Gossrau R. Co-localization of nitric oxide synthase I (NOS I) and NMDA receptor subunit 1 (NMDAR-1) at the neuromuscular junction in rat and mouse skeletal muscle. Cell Tissue Res. 1997;291:57\u201363. https:\/\/doi.org\/10.1007\/s004410050979.","journal-title":"Cell Tissue Res"},{"key":"7353_CR25","doi-asserted-by":"crossref","unstructured":"Patterson GT, Wilson BW. Distribution of acetylcholinesterase activity in normal, dystrophic, and denervated muscles of the chicken. Exp Neurol. 1976;52:250\u2013262.","DOI":"10.1016\/0014-4886(76)90169-2"},{"key":"7353_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13578-022-00829-z","volume":"12","author":"S Zou","year":"2022","unstructured":"Zou S, Pan BX. Post-synaptic specialization of the neuromuscular junction: junctional folds formation, function, and disorders. Cell Biosci. 2022;12:93. https:\/\/doi.org\/10.1186\/s13578-022-00829-z.","journal-title":"Cell Biosci"},{"key":"7353_CR27","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.3390\/life12111861","volume":"12","author":"M Morotti","year":"2022","unstructured":"Morotti M, Gaeta A, Limatola C, Catalano M, Di Castro MA, Grassi F. Early developmental changes of muscle acetylcholine receptors are little influenced by dystrophin absence in mdx mouse. Life. 2022;12:1861. https:\/\/doi.org\/10.3390\/life12111861.","journal-title":"Life"},{"key":"7353_CR28","doi-asserted-by":"publisher","first-page":"581097","DOI":"10.3389\/fnmol.2020.581097","volume":"13","author":"H Cetin","year":"2020","unstructured":"Cetin H, Beeson D, Vincent A, Webster R. The structure, function, and physiology of the fetal and adult acetylcholine receptor in muscle. Front Mol Neurosci. 2020;13:581097. https:\/\/doi.org\/10.3389\/fnmol.2020.581097.","journal-title":"Front Mol Neurosci"},{"key":"7353_CR29","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1080\/14728222.2017.1369960","volume":"21","author":"K Ohno","year":"2017","unstructured":"Ohno K, Ohkawara B, Ito M. Agrin-LRP4-MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders. Expert Opin Ther Targets. 2017;21:949\u201358.","journal-title":"Expert Opin Ther Targets"},{"key":"7353_CR30","doi-asserted-by":"publisher","first-page":"9186","DOI":"10.1523\/JNEUROSCI.2683-19.2020","volume":"40","author":"KC Hoy","year":"2020","unstructured":"Hoy KC, Strain MM, Turtle JD, Lee KH, Huie JR, Hartman JJ, et al. Evidence that the central nervous system can induce a modification at the neuromuscular junction that contributes to the maintenance of a behavioral response. J Neurosci. 2020;40:9186\u2013209. https:\/\/doi.org\/10.1523\/JNEUROSCI.2683-19.2020.","journal-title":"J Neurosci"},{"key":"7353_CR31","doi-asserted-by":"publisher","unstructured":"Farup J, Madaro L, Puri PL, Mikkelsen UR. Interactions between muscle stem cells, mesenchymal-derived cells and immune cells in muscle homeostasis, regeneration and disease. Cell Death Dis. 2015;6(7):e1830. https:\/\/doi.org\/10.1038\/cddis.2015.198.","DOI":"10.1038\/cddis.2015.198"},{"key":"7353_CR32","doi-asserted-by":"publisher","unstructured":"Renzini A, Riera CS, Minic I, D\u2019ercole C, Lozanoska\u2010ochser B, Cedola A. et al. Metabolic remodeling in skeletal muscle atrophy as a therapeutic target. Metabolites. 2021;11(8):517. https:\/\/doi.org\/10.3390\/metabo11080517.","DOI":"10.3390\/metabo11080517"},{"key":"7353_CR33","doi-asserted-by":"publisher","first-page":"107114","DOI":"10.1016\/j.isci.2023.107114","volume":"26","author":"C Nicoletti","year":"2023","unstructured":"Nicoletti C, Wei X, Etxaniz U, D\u2019Ercole C, Madaro L, Perera R, et al. Muscle denervation promotes functional interactions between glial and mesenchymal cells through NGFR and NGF. iScience. 2023;26:107114. https:\/\/doi.org\/10.1016\/j.isci.2023.107114.","journal-title":"iScience"},{"key":"7353_CR34","doi-asserted-by":"publisher","first-page":"111861","DOI":"10.1016\/j.celrep.2022.111861","volume":"41","author":"C D\u2019Ercole","year":"2022","unstructured":"D\u2019Ercole C, D\u2019Angelo P, Ruggieri V, Proietti D, Virtanen L, Parisi C, et al. Spatially resolved transcriptomics reveals innervation-responsive functional clusters in skeletal muscle. Cell Rep. 2022;41:111861. https:\/\/doi.org\/10.1016\/j.celrep.2022.111861.","journal-title":"Cell Rep"},{"key":"7353_CR35","doi-asserted-by":"publisher","first-page":"1202834","DOI":"10.3389\/fimmu.2023.1202834","volume":"14","author":"Lemos","year":"2023","unstructured":"Lemos, Ten\u00f3rio JP, Mouly LPG, Butler-Browne V, Mendes-da-Cruz DA G, Savino W, et al. T cell biology in neuromuscular disorders: a focus on duchenne muscular dystrophy and amyotrophic lateral sclerosis. Front Immunol. 2023;14:1202834. https:\/\/doi.org\/10.3389\/fimmu.2023.1202834.","journal-title":"Front Immunol"},{"key":"7353_CR36","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.mcn.2008.12.011","volume":"40","author":"GB Banks","year":"2009","unstructured":"Banks GB, Chamberlain JS, Froehner SC. Truncated dystrophins can influence neuromuscular synapse structure. Mol Cell Neurosci. 2009;40:433\u201341. https:\/\/doi.org\/10.1016\/j.mcn.2008.12.011.","journal-title":"Mol Cell Neurosci"},{"key":"7353_CR37","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1083\/jcb.150.6.1385","volume":"150","author":"ME Adams","year":"2000","unstructured":"Adams ME, Kramarcy N, Krall SP, Rossi SG, Rotundo RL, Sealock R, et al. Absence of \u03b1-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin. J Cell Biol. 2000;150:1385\u201398. https:\/\/doi.org\/10.1083\/jcb.150.6.1385.","journal-title":"J Cell Biol"},{"key":"7353_CR38","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/15519","volume":"23","author":"PD C\u00f4t\u00e9","year":"1999","unstructured":"C\u00f4t\u00e9 PD, Moukhles H, Lindenbaum M, Carbonetto S. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat Genet. 1999;23:338\u201342. https:\/\/doi.org\/10.1038\/15519.","journal-title":"Nat Genet"},{"key":"7353_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-6-262","volume":"6","author":"SJ Pratt","year":"2013","unstructured":"Pratt SJ, Xu S, Mullins RJ, Lovering RM. Temporal changes in magnetic resonance imaging in the mdx mouse. BMC Res Notes. 2013;6:262.","journal-title":"BMC Res Notes"},{"key":"7353_CR40","doi-asserted-by":"crossref","unstructured":"Pratt SJP, Iyer SR, Shah SB, Lovering RM. Imaging analysis of the neuromuscular junction in dystrophic muscle. Method Mol Biol. 2018;1687:57\u201372.","DOI":"10.1007\/978-1-4939-7374-3_5"},{"key":"7353_CR41","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fphys.2015.00252","volume":"6","author":"SJP Pratt","year":"2015","unstructured":"Pratt SJP, Valencia AP, Le GK, Le SB, Shah RM. Pre- and postsynaptic changes in the neuromuscular junction in dystrophic mice. Front Physiol. 2015;6:252. https:\/\/doi.org\/10.3389\/fphys.2015.00252.","journal-title":"Front Physiol"},{"key":"7353_CR42","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/mus.880170212","volume":"17","author":"Y Mizuno","year":"1994","unstructured":"Mizuno Y, Yoshida M, Nonaka I, Hirai S, Ozawa E. Expression of utrophin (dystrophin\u2010related protein) and dystrophin\u2010associated glycoproteins in muscles from patients with Duchenne muscular dystrophy. Muscle Nerve. 1994;17:206\u201316. https:\/\/doi.org\/10.1002\/mus.880170212.","journal-title":"Muscle Nerve"},{"key":"7353_CR43","doi-asserted-by":"crossref","unstructured":"Ohlendieck K, Ervasti JM, Matsumura K, Kahl SD, Leveille CJ, Campbell KP. Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. 1991;7:499\u2013508.","DOI":"10.1016\/0896-6273(91)90301-F"},{"key":"7353_CR44","doi-asserted-by":"publisher","unstructured":"Fornetti E, Testa S, De Paolis F, Fuoco C, Bernardini S, Pozo Devoto V. et al. Dystrophic muscle affects motoneuron axon outgrowth and NMJ assembly. Adv Mater Technol. 2022;7:2101216. https:\/\/doi.org\/10.1002\/admt.202101216.","DOI":"10.1002\/admt.202101216"},{"key":"7353_CR45","doi-asserted-by":"publisher","first-page":"8860","DOI":"10.1523\/JNEUROSCI.0860-18.2018","volume":"38","author":"K Zhao","year":"2018","unstructured":"Zhao K, Shen C, Li L, Wu H, Xing G, Dong Z, et al. Sarcoglycan alpha mitigates neuromuscular junction decline in aged mice by stabilizing LRP4. J Neurosci. 2018;38:8860\u201373.","journal-title":"J Neurosci"},{"key":"7353_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20063-w","volume":"11","author":"MJ Petrany","year":"2020","unstructured":"Petrany MJ, Swoboda CO, Sun C, Chetal K, Chen X, Weirauch MT, et al. Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers. Nat Commun. 2020;11:6374 https:\/\/doi.org\/10.1038\/s41467-020-20063-w.","journal-title":"Nat Commun"},{"key":"7353_CR47","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1097-2765(00)80410-4","volume":"5","author":"M Durbeej","year":"2000","unstructured":"Durbeej M, Cohn RD, Hrstka RF, Moore SA, Allamand V, Davidson BL, et al. Disruption of the \u03b2-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. Mol Cell. 2000;5:141\u201351.","journal-title":"Mol Cell"},{"key":"7353_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74192-9","volume":"10","author":"RT Massopust","year":"2020","unstructured":"Massopust RT, Lee Y, Pritchard AL, Nguyen VKM, McCreedy DA, Thompson WJ. Lifetime analysis of mdx skeletal muscle reveals a progressive pathology that leads to myofiber loss. Sci Rep. 2020;10:17248 https:\/\/doi.org\/10.1038\/s41598-020-74192-9.","journal-title":"Sci Rep"},{"key":"7353_CR49","doi-asserted-by":"publisher","first-page":"e143469","DOI":"10.1172\/jci.insight.143469","volume":"6","author":"D Proietti","year":"2021","unstructured":"Proietti D, Giordani L, De Bardi M, D\u2019Ercole C, Lozanoska-Ochser B, Amadio S, et al. Activation of skeletal muscle-resident glial cells upon nerve injury. JCI Insight. 2021;6:e143469. https:\/\/doi.org\/10.1172\/jci.insight.143469.","journal-title":"JCI Insight"},{"key":"7353_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61347-x","volume":"10","author":"M P\u0119zi\u0144ski","year":"2020","unstructured":"P\u0119zi\u0144ski M, Daszczuk P, Pradhan BS, Lochm\u00fcller H, Pr\u00f3szy\u0144ski TJ. An improved method for culturing myotubes on laminins for the robust clustering of postsynaptic machinery. Sci Rep. 2020;10:4524 https:\/\/doi.org\/10.1038\/s41598-020-61347-x.","journal-title":"Sci Rep"},{"key":"7353_CR51","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/mus.20640","volume":"34","author":"RA Draviam","year":"2006","unstructured":"Draviam RA, Shand SH, Watkins SC. The \u03b2-\u03b4-core of sarcoglycan is essential for deposition at the plasma membrane. Muscle Nerve. 2006;34:691\u2013701. https:\/\/doi.org\/10.1002\/mus.20640.","journal-title":"Muscle Nerve"},{"key":"7353_CR52","doi-asserted-by":"crossref","unstructured":"Hack AA, Ly CT, Jiang F, Clendenin CJ, Sigrist KS, Wollmann RL et al. Sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. 1998;142:1279\u201387.","DOI":"10.1083\/jcb.142.5.1279"},{"key":"7353_CR53","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S1050-1738(03)00101-4","volume":"13","author":"M Wheeler","year":"2003","unstructured":"Wheeler M. McNally EM. Sarcoglycans in vascular smooth and striated muscle. Trends Cardiovasc Med. 2003;13:238\u201343. https:\/\/doi.org\/10.1016\/S1050-1738(03)00101-4.","journal-title":"Trends Cardiovasc Med"},{"key":"7353_CR54","doi-asserted-by":"publisher","first-page":"135304","DOI":"10.1016\/j.neulet.2020.135304","volume":"737","author":"RM Lovering","year":"2020","unstructured":"Lovering RM, Iyer SR, Edwards B, Davies KE. Alterations of neuromuscular junctions in Duchenne muscular dystrophy. Neurosci Lett. 2020;737:135304. https:\/\/doi.org\/10.1016\/j.neulet.2020.135304.","journal-title":"Neurosci Lett"},{"key":"7353_CR55","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neuroscience.2019.05.017","volume":"439","author":"CR Slater","year":"2020","unstructured":"Slater CR. Fragmentation\u2019 of NMJs: a sign of degeneration or regeneration? a long journey with many junctions. Neuroscience. 2020;439:28\u201340.","journal-title":"Neuroscience"},{"key":"7353_CR56","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1042\/BJ20031644","volume":"381","author":"D Sandon\u00e0","year":"2004","unstructured":"Sandon\u00e0 D, Gastaldello S, Martinello T, Betto R. Characterization of the ATP-hydrolysing activity of \u03b1-sarcoglycan. Biochem J. 2004;381:105\u201312. https:\/\/doi.org\/10.1042\/BJ20031644.","journal-title":"Biochem J"},{"key":"7353_CR57","doi-asserted-by":"publisher","first-page":"7907","DOI":"10.1074\/jbc.274.12.7907","volume":"274","author":"R Betto","year":"1999","unstructured":"Betto R, Senter L, Ceoldo S, Tarricone E, Biral D, Salviati G. Ecto-ATPase activity of \u03b1-sarcoglycan (adhalin). J Biol Chem. 1999;274:7907\u201312. https:\/\/doi.org\/10.1074\/jbc.274.12.7907.","journal-title":"J Biol Chem"},{"key":"7353_CR58","doi-asserted-by":"publisher","first-page":"6423","DOI":"10.3390\/ijms21176423","volume":"21","author":"AU Ziganshin","year":"2020","unstructured":"Ziganshin AU, Khairullin AE, Hoyle CHV, Grishin SN. Modulatory roles of ATP and adenosine in cholinergic neuromuscular transmission. Int J Mol Sci. 2020;21:6423. https:\/\/doi.org\/10.3390\/ijms21176423.","journal-title":"Int J Mol Sci"},{"key":"7353_CR59","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1017\/S1462399409001203","volume":"11","author":"D Sandon\u00e0","year":"2009","unstructured":"Sandon\u00e0 D, Betto R. Sarcoglycanopathies: Molecular pathogenesis and therapeutic prospects. Expert Rev Mol Med. 2009;11:e28. https:\/\/doi.org\/10.1017\/S1462399409001203.","journal-title":"Expert Rev Mol Med"},{"key":"7353_CR60","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s42003-021-02810-x","volume":"4","author":"DW McKellar","year":"2021","unstructured":"McKellar DW, Walter LD, Song LT, Mantri M, Wang MFZ, De Vlaminck I, et al. Large-scale integration of single-cell transcriptomic data captures transitional progenitor states in mouse skeletal muscle regeneration. Commun Biol. 2021;4:1280. https:\/\/doi.org\/10.1038\/s42003-021-02810-x.","journal-title":"Commun Biol"},{"key":"7353_CR61","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM, et al. Comprehensive integration of single-cell data. Cell. 2019;177:1888\u20131902.e21. https:\/\/doi.org\/10.1016\/j.cell.2019.05.031.","journal-title":"Cell"},{"key":"7353_CR62","doi-asserted-by":"crossref","unstructured":"Jones RA, Reich CD, Dissanayake KN, Kristmundsdottir F, Findlater GS, Ribchester RR. et al. Correction to NMJ-morph reveals principal components of synaptic morphology influencing structure - function relationships at the neuromuscular junction. Open Biol. 2016;6(12):160240.","DOI":"10.1098\/rsob.160240"},{"key":"7353_CR63","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/0143-4160(95)90109-4","volume":"17","author":"JM Millot","year":"1995","unstructured":"Millot JM, Pingret L, Angiboust JF, Bonhomme A, Pinon JM, Manfait M. Quantitative determination of free calcium in subcellular compartments, as probed by Indo-1 and confocal microspectrofluorometry. Cell Calcium. 1995;17:354\u201366. https:\/\/doi.org\/10.1016\/0143-4160(95)90109-4.","journal-title":"Cell Calcium"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07353-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07353-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07353-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T16:08:24Z","timestamp":1737562104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07353-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7353"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07353-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have declared no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}